June has proven to be a pretty decent month so far for the overall markets. For three health-care stocks, the third week of the month wasn't just decent. Gains of over 25% in a matter of days probably qualify as great.
One of this week's big winners received exciting news from the U.S. Food and Drug Administration. Another reported promising early results from a clinical study. And yet another company is getting acquired by a rival for hefty price tag.
Which three stocks soared above the market this week? Find out by watching the slideshow below.
Leaked: This coming blockbuster will make every biotech jealous
The best biotech investors consistently reap gigantic profits by recognizing true potential earlier and more accurately than anyone else. Let me cut right to the chase. There is a product in development that will revolutionize not how we treat a common chronic illness, but potentially the entire health industry. Analysts are already licking their chops at the sales potential. In order to outsmart Wall Street and realize multi-bagger returns you will need The Motley Fool’s new free report on the dream-team responsible for this game-changing blockbuster. CLICK HERE NOW.
Keith Speights has no position in any stocks mentioned. The Motley Fool recommends Covidien. The Motley Fool owns shares of Medtronic. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.